ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

RFA For Patterns Of Care Study in Elderly Issues

January 14, 1983

Cancer Groups Criticize Prescription Drug Bills.

June 27, 2003

St. Jude, Washington University Plan $65 Million Pediatric Cancer Genome Project

January 29, 2010

NCI Programs: First Raid Awardees, Drug Development Projects, Listed

March 26, 1999

Cancer Control Reps Discuss Issues of ‘80s

October 17, 1980

Chabner On Taxol, NSABP: “Makes You Lose Confidence In The Political Process”

May 12, 1995